Track record · closed signal

CareTrust REIT, Inc. (CTRE) — closed signal from October 22, 2025

Target reached Published before the outcome was known, scored automatically when the window closed on January 20, 2026.

Predicted vs. what happened

CTRE price · publication thesis → realized outcomesplit-adjusted
$34.10 Published $37.85 Target $37.35 Window close $38.23 Peak
$33.39 – $34.17Entry zone — fair-value band
$34.10Published — price the day we called it
$37.85Target — the price the thesis aimed for
$38.23Peak — highest point inside the window, not a realized return
$37.35Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 79 days.

Peak price
$38.23
peak on January 9, 2026 — not a realized return
Peak gain
+12.1%
peak, from the publication price
Window close
$37.35
end-of-window price, context only
Days to target
79
Window
October 22, 2025 – January 20, 2026

The thesis — published October 22, 2025

Predicted growth
+12%
over the measurement window
Target price
$37.85
the price the thesis aimed for
Entry zone
$33.39 – $34.17
the fair-value band we waited for
Price at publication
$34.10
published October 22, 2025
Confidence
86%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

CareTrust looks set for a steady 3-month hold because business results and price action point the same way. More buyers than usual and positive mood line up with solid finances. Recent news: it bought two care homes in the UK and raised its dividend to almost 4%, adding income appeal. Analysts see about 10% upside. Main risk is rising interest rates, but reliable tenants and smart deals support steady progress.

Primary drivers

  • Higher dividend makes the stock more attractive for steady, reliable income.
  • Buying UK care sites grows the property list and future rent checks.
  • Stronger buying interest suggests the current upward price trend can hold.
  • Good mood plus solid basics point to dependable, low-drama progress.

How it played out

CTRE: target reached in 79 days

Lyra published CTRE at 34.10 on October 22, 2025, with a 12% expected gain over a short-term window. The thesis pointed to a higher dividend, UK care-site purchases, stronger buying interest, good mood, and solid basics. It also cited rising interest rates as the main risk.

Inside the window, the stock reached the 37.85 target. It peaked at 38.23 on January 9, 2026, a 12.1% gain, and did so in 79 days. By January 20, 2026, it ended at 37.35. The thesis played out.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.